Evidence map›Paper›PMID 33138142›Full record

ReviewMicroorganisms2020

Why the Anti-Meningococcal B Vaccination during Adolescence Should Be Implemented in Italy: An Overview of Available Evidence.

Sara Boccalini, Beatrice Zanella, Paolo Landa, Daniela Amicizia, Angela Bechini, Maddalena Innocenti, Mariasilvia Iovine, Elvina Lecini, Francesca Marchini, Diana Paolini and 5 more

Open access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Microorganisms, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Meningococcal Disease in Pediatric Age: A Focus on Epidemiology and Prevention.International journal of environmental research and public health · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 2 countries.

Sara BoccaliniDepartment of Health Sciences, University of Florence, 50134 Florence, Italy.ORCID 0000-0002-9695-7549
Beatrice ZanellaDepartment of Health Sciences, University of Florence, 50134 Florence, Italy.ORCID 0000-0001-6718-1932
Paolo LandaDepartment of Economics, University of Genoa, 16132 Genoa, Italy.ORCID 0000-0001-6532-6747
Daniela AmiciziaDepartment of Health Sciences, University of Genoa, 16132 Genoa, Italy.ORCID 0000-0002-9707-5214
Angela BechiniDepartment of Health Sciences, University of Florence, 50134 Florence, Italy.ORCID 0000-0002-6013-8779
Maddalena InnocentiAUSL Toscana Centro, 50122 Florence, Italy.
Mariasilvia IovineDepartment of Health Sciences, University of Genoa, 16132 Genoa, Italy.
Elvina LeciniDepartment of Health Sciences, University of Genoa, 16132 Genoa, Italy.
Francesca MarchiniDepartment of Health Sciences, University of Genoa, 16132 Genoa, Italy.
Diana PaoliniHealth Management Unit, Careggi University Hospital, 50134 Florence, Italy.ORCID 0000-0001-8062-5710
Gino SartorDepartment of Health Sciences, University of Florence, 50134 Florence, Italy.
Francesca ZangrilloPrevention Department, Public Health Office, ASL2 Liguria, Italy.ORCID 0000-0002-2854-9711
Piero Luigi LaiDepartment of Health Sciences, University of Genoa, 16132 Genoa, Italy.
Paolo BonanniDepartment of Health Sciences, University of Florence, 50134 Florence, Italy.ORCID 0000-0003-2875-3744
Donatella PanattoDepartment of Health Sciences, University of Genoa, 16132 Genoa, Italy.ORCID 0000-0002-2677-0551
University of Genoa · ITUniversity of Florence · ITAzienda Ospedaliero-Universitaria Careggi · ITAzienda Usl Toscana Centro · ITUniversité Laval · CA

Funding

Pfizer 3225/17
6 · The paper itself

Abstract

Although meningococcal disease has a low incidence in Italy, it is a public health concern owing to its high lethality rate and high frequency of transitory and/or permanent sequelae among survivors. The highest incidence rates are recorded in infants, children and adolescents, and most of the cases are due to

Indexed as

adolescentsanti-MenB vaccination strategymeningococcal B vaccinemeningococcal disease burdenmeningococcal economic burdenNeisseria meningitidis B

Identifiers

PMID33138142
PMCPMC7692044
OpenAlexW3095916653

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.